ABSTRACT

Balestrini et al. show the identification of a TRPA1 inhibitor that suppresses airway smooth muscle contraction, inflammation, edema, and cough in preclinical models and show target engagement in humans, demonstrating that pharmacologic inhibition of TRPA1 is a promising therapy for asthma.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-100 of 107 references · Page 1 of 2

CITED BY

Showing 1-100 of 116 citing papers · Page 1 of 2